Nisa Lluís, Salmina Cinzia, Dettmer Matthias Stephan, Arnold Andreas, Aebersold Daniel Matthias, Borner Urs, Giger Roland
Department of Otorhinolaryngology-Head & Neck Surgery, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Laryngoscope. 2015 Sep;125(9):2099-106. doi: 10.1002/lary.25342. Epub 2015 May 6.
OBJECTIVES/HYPOTHESIS: Assess the diagnostic and prognostic relevance of intraglandular lymph node (IGLN) metastases in primary parotid gland carcinomas (PGCs).
Retrospective study at a tertiary referral university hospital.
We reviewed the records of 95 patients with primary PGCs, treated at least surgically, between 1997 and 2010. We assessed the clinicopathological associations of IGLN metastases, their prognostic significance, and predictive value in the diagnosis of occult neck lymph node metastases
Twenty-four (25.26%) patients had IGLN metastases. This feature was significantly more prevalent in patients with advanced pT status (P = .01), pN status (P < .01), and overall stage (P < .001); high-risk carcinomas (P = .01); as well as in patients with treatment failures (P < .01). IGLN involvement was significantly associated with decreased univariate disease-free survival (P < .001). Positive and negative predictive values and accuracy for IGLN involvement in the detection of occult neck lymph node metastases were 63.64%, 90.48%, and 84.91%, respectively. The diagnostic values were generally higher in patients with low-risk subtype of PGCs.
IGLN involvement provides prognostic information and is associated with advanced tumoral stage and higher risk of recurrence. This feature could be used as a potential readout to determine whether a neck dissection in clinically negative neck lymph nodes is needed or not.
目的/假设:评估原发性腮腺癌(PGC)中腺内淋巴结(IGLN)转移的诊断及预后相关性。
在一所三级转诊大学医院进行的回顾性研究。
我们回顾了1997年至2010年间至少接受过手术治疗的95例原发性PGC患者的记录。我们评估了IGLN转移的临床病理相关性、其预后意义以及在隐匿性颈部淋巴结转移诊断中的预测价值。
24例(25.26%)患者存在IGLN转移。这一特征在pT分期较晚(P = 0.01)、pN分期较晚(P < 0.01)以及总分期较晚(P < 0.001)的患者中更为常见;在高危癌患者中(P = 0.01);以及在治疗失败的患者中(P < 0.01)。IGLN受累与单因素无病生存率降低显著相关(P < 0.001)。IGLN受累在检测隐匿性颈部淋巴结转移中的阳性预测值、阴性预测值及准确性分别为63.64%、90.48%和84.91%。在低风险亚型的PGC患者中,诊断价值通常更高。
IGLN受累提供了预后信息,并且与肿瘤晚期及更高的复发风险相关。这一特征可作为一种潜在指标,用于确定是否需要对临床检查阴性的颈部淋巴结进行清扫。
4级。